Sign in

CIK 0001087294 · Non-accelerated filer<br>Smaller reporting company

CUMBERLAND PHARMACEUTICALS INC

Sign in to watch
Ticker
CPIX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
TN
Entity type
operating
EIN
621765329
Phone
615-255-0068
Business address
1600 WEST END AVENUE, SUITE 1300, NASHVILLE,, TN, 37203
  1. 4 Grant or award Sr. VP & Corp. Secretary acquired 3,000 shares (grant or award)
  2. 4 Grant or award Vice President and CFO acquired 3,000 shares (grant or award)
  3. 4 Grant or award Chairman and CEO acquired 25,000 shares (grant or award)
  4. 4 Grant or award Director acquired 1,000 shares (grant or award)
  5. 4 Grant or award Director acquired 1,000 shares (grant or award)
  6. 4 Grant or award Director acquired 1,000 shares (grant or award)
  7. 4 Grant or award Director acquired 1,000 shares (grant or award)
  8. 4 Grant or award Director acquired 1,000 shares (grant or award)
  9. 4 Grant or award Sr VP/Chief Commercial Officer acquired 3,000 shares (grant or award)
  10. 4 Grant or award Director acquired 1,000 shares (grant or award)
  11. 4 Open-market buy Director bought 50,000 shares at an average $5.15 ($257,579)
  12. 3 Insider Initial Statement of Ownership
  13. 4 Option exercise Director acquired 60,500 shares (option exercise)
  14. 4 Option exercise Sr VP/Chief Commercial Officer acquired 7,400 shares (option exercise)
  15. 4 Option exercise Director acquired 37,158 shares (option exercise)
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Open-market buy Director bought 3,000 shares at $6.90 ($20,703)
  20. 4 Open-market buy Director bought 5,900 shares at $6.80 ($40,120)

Page 24 of 26 · 512 filings